Abstract:
The article focuses on a study by researcher R. Padwal and colleagues, which reports on the pharmacologic prevention of type 2 diabetes mellitus. The study found that in patients with type 2 diabetes mellitus, some oral hypoglycemic agents and antiobesity drugs reduce the incidence of diabetes, but the findings are inconsistent and many studies have low patient follow-up or show high drug-related gastrointestinal adverse effects. It is concluded that no single agent is a clear choice for preventing diabetes in patients with impaired glucose tolerance..